Dr. Rishi Ganesan
Assistant Professor
P: 519.685.8500 x74702
E-mail: rishi.ganesan@lhsc.on.ca
Appointments
- Pediatric critical care physician, Children's Hospital - London Health Sciences Centre
- Pediatric Neurorehabilitation/ Acquired brain injury physician, Children's Hospital - LHSC
- Assistant Professor, Department of Paediatrics
- Cross Appointed to Department of Clinical Neurological Sciences
- Department of Physiology & Pharmacology
- Department of Medical Biophysics
- Member, Neurosciences Program, School of Graduate & Postdoctoral studies
- Hospital Donation Physician, Children's Hospital - LHSC, Ontario Health (Trillium Gift of Life Network)
Research Cluster Membership
- Clinical Epidemiology
- Epidemiological observational studies
- Evidence Synthesis & Health Technology Assessment
- Knowledge Translation
- Randomized Controlled Trials
Research Interests
- Pediatric Neurocritical care
- Neuroprognostication
- Disorders of Cognition (e.g. delirium)
- Disorders of Consciousness (e.g. coma)
- Clinical Trials
- Bayesian & platform trials
- Functional neuroimaging
Biography
Dr. Rishi Ganesan is a paediatric critical care physician-researcher at the Children's Hospital - LHSC, and an Assistant Professor in the Depts. of Paediatrics and Clinical Neurological Sciences at the Schulich School of Medicine & Dentistry, Western University, London (ON), Canada. Dr. Ganesan's clinical-research training in paediatrics, critical care, neurology and neurocritical care is very unique and positions him well to be a leader in this space. He is passionate about improving diagnosis and treatment of altered states of cognition and consciousness in critically ill patients. His research program aims to improve long-term functional outcomes in critically ill children through the testing and validation of advanced electrical and functional neuroimaging tools for prediction and detection of pathological brain states. This line of work will empower bedside critical care providers with the tools, knowledge, and skills to identify evolving brain pathologies quickly and determine prognosis objectively in high-risk critically ill children with acquired brain injury. His program utilizes observational studies, randomized clinical trials and knowledge translation to achieve these goals.
